Laurie Schenkel
About Laurie Schenkel
Laurie Schenkel is a Senior Director of Medicinal Chemistry at MOMA Therapeutics, where she has worked since 2020. She has a background in biochemistry and chemistry, holding a BA from the University of Pennsylvania and a PhD from the University of California, Berkeley.
Work at MOMA Therapeutics
Laurie Schenkel has served as the Senior Director of Medicinal Chemistry at MOMA Therapeutics since 2020. In this role, she is responsible for leading medicinal chemistry efforts and overseeing the development of innovative therapeutic solutions. MOMA Therapeutics focuses on harnessing the power of targeted therapies to address unmet medical needs. Schenkel's expertise in medicinal chemistry contributes to the company's mission of advancing drug discovery and development.
Previous Experience at Ribon Therapeutics
Before joining MOMA Therapeutics, Laurie Schenkel worked at Ribon Therapeutics as an Associate Director from 2017 to 2020. During her tenure in Cambridge, Massachusetts, she played a key role in advancing the company's research initiatives. Her experience at Ribon Therapeutics enhanced her skills in medicinal chemistry and drug development, further preparing her for her current position.
Career at Amgen
Laurie Schenkel spent 11 years at Amgen, where she held the position of Senior Scientist from 2005 to 2016. Based in Cambridge, Massachusetts, she contributed to various projects focused on biopharmaceutical development. Her extensive experience at Amgen provided her with a solid foundation in the pharmaceutical industry, particularly in the areas of drug discovery and development.
Education and Expertise
Laurie Schenkel earned her Bachelor of Arts in Biochemistry from the University of Pennsylvania, where she studied from 1996 to 2000. She then pursued a PhD in Chemistry at the University of California, Berkeley, completing her studies from 2000 to 2005. Her educational background equips her with a strong understanding of the principles of chemistry and biochemistry, which are essential in her roles within the pharmaceutical industry.